EBD Group is part of the KNect365 of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Biotech Showcase 2015 EBD Group Demy-Colton
Share/Follow Us
Share this:
Follow this event:

Biotech Showcase™ Press Releases

News for Biotech Showcase™ 2017 will be available soon.

January 27, 2016Biotech Showcase™ 2016 reports record high attendance this year A record number of life science industry executives attended the eighth annual Biotech Showcase investor and networking conference, held January 11–13 in San Francisco. More than 2,500 executive-level delegates representing qualified private and public equity investors, industry analysts, bankers, pharmaceutical and biotechnology industry executives attended from 1,600...  more ►

December 22, 2016Biotech Showcase™ 2016 will be "home base" for investment community in San Francisco in January The eighth annual Biotech Showcase investor and networking conference will be held in San Francisco during the healthcare industry's busiest week of the year, January 11–13, 2016. The event acts as home base for innovative mid-small cap and private life sciences companies and the public, private and strategic investors eager to meet with them. Over 300 innovative comp...  more ►

November 10, 2015The 8th Annual Biotech Showcase will celebrate life sciences innovations in January 2016 amid the largest healthcare investor conference of the year The eighth annual Biotech Showcase investor and networking conference will be held January 11–13, 2016 in San Francisco, CA at Parc 55 San Francisco - A Hilton Hotel. The event is expected to bring together 2,100+ attendees representing the life science industry's most enterprising and pioneering biotech companies and major players in the drug development arena. The pr...  more ►

partnering360® Blog

April 29, 2016 Digital Health: Still a brave new world At this year’s BIO-Europe Spring® panel on “The Convergence of Therapeutics and Digital Health,” two panelists from big pharma joined two from Scandinavian digital health companies, agreeing that while the platform for digital health technologies is strong in Europe, much... more ►

April 19, 2016 The characteristics of a “winning” biotech startup QureTech Bio AB, a startup developing first line drugs to combat antibiotic resistance and infectious diseases, won the Start-up Slam: Sweden biotech competition at BIO-Europe Spring® 2016 in Stockholm, Sweden earlier this month. QureTech Bio AB participated in the pitching competition sponsored by... more ►

April 5, 2016 Images of BIO-Europe Spring® 2016 in Stockholm [See image gallery at www.partnering360.com] more ►

April 5, 2016 BIO-Europe Spring® 2016 Monday recap BIO-Europe Spring® 2016 kicked off in Stockholm, Sweden yesterday with a full program and hundreds of partnering meetings.   Morning workshops ranged from new partnerships and market access to precision medicine and vaccine development.   Mid-morning, the Stockholm Business Region... more ►

April 2, 2016 Is it possible to create new business out of clinical needs? Guest post by Björn Varnestig, CEO, Flemingsberg Science   During a period of three years, we let a group of experienced business developers (we call them business architects) walk the corridors of the Karolinska University Hospital, talking to people about the problems, needs and... more ►

partnering360:Insight Latest headlines from partnering360:Insight

April 28, 2016 PledPharma seeks partner for lead therapy Jacques Näsström, CEO of PledPharma, chats with Sten Stovall about the company’s current hunt for licensing partners for lead product PledOx (calmangafodipir). more ►

April 28, 2016 Affibody CEO describes three-year growth plan Affibody CEO David Bejker discusses the biotech's four key drug and diagnostic development programs and future plans for growing the company's portfolio of antibody mimetics. more ►

April 28, 2016 New VC bioqube on open innovation roots and investments targets Nico Vandervelpen, managing partner and co-founder of bioqube ventures, and Informa Pharma Intelligence's Mike Ward discuss the young venture capital firm's big plans for the future. more ►

April 28, 2016 QureTech Bio explains novel approach to antibiotic development CEO of QureTech Bio Dr. Fritiof Pontén explains how his company's novel class of antibacterial agents might help provide a solution to the current global crisis of antibiotic resistance. more ►

April 28, 2016 CEVEC CEO talks US deals to expand business CEVEC chief Frank Ubags speaks with Scrip's Lucie Ellis about how the platform technology company is enabling gene therapy companies to move their products into large scale clinical trials. more ►

Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group
Privacy Policy and Cookies
Terms of Use